{
    "organizations": [],
    "uuid": "aecbc2c7db53ebb4a272bc55bd52810fd3b124d9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-moleculin-biotech-inc-has-been-abl/brief-moleculin-biotech-inc-has-been-able-to-show-promising-tumor-suppression-activity-with-its-inhibitor-of-glycolysis-wp1122-idUSFWN1PX1A3",
    "ord_in_thread": 0,
    "title": "BRIEF-Moleculin Biotech Inc - Has Been Able To Show Promising Tumor Suppression Activity With Its Inhibitor Of Glycolysis, Wp1122",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Moleculin Biotech Inc:\n* MOLECULIN BIOTECH INC - HAS BEEN ABLE TO SHOW PROMISING TUMOR SUPPRESSION ACTIVITY WITH ITS INHIBITOR OF GLYCOLYSIS, WP1122 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-07T21:42:00.000+02:00",
    "crawled": "2018-02-09T05:35:54.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "moleculin",
        "biotech",
        "inc",
        "moleculin",
        "biotech",
        "inc",
        "able",
        "show",
        "promising",
        "tumor",
        "suppression",
        "activity",
        "inhibitor",
        "glycolysis",
        "wp1122",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}